rs139478143

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_001101426.4(CRPPA):​c.1026+45_1026+46delAT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.124 in 1,194,472 control chromosomes in the GnomAD database, including 10,114 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.091 ( 798 hom., cov: 31)
Exomes 𝑓: 0.13 ( 9316 hom. )

Consequence

CRPPA
NM_001101426.4 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.34

Publications

1 publications found
Variant links:
Genes affected
CRPPA (HGNC:37276): (CDP-L-ribitol pyrophosphorylase A) This gene encodes a 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein. Mutations in this gene are the cause of Walker-Warburg syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2012]
CRPPA-AS1 (HGNC:48962): (CRPPA antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 7-16258873-CAT-C is Benign according to our data. Variant chr7-16258873-CAT-C is described in ClinVar as Benign. ClinVar VariationId is 257461.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.137 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRPPANM_001101426.4 linkc.1026+45_1026+46delAT intron_variant Intron 7 of 9 ENST00000407010.7 NP_001094896.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRPPAENST00000407010.7 linkc.1026+45_1026+46delAT intron_variant Intron 7 of 9 5 NM_001101426.4 ENSP00000385478.2

Frequencies

GnomAD3 genomes
AF:
0.0908
AC:
13803
AN:
151968
Hom.:
798
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0256
Gnomad AMI
AF:
0.112
Gnomad AMR
AF:
0.0726
Gnomad ASJ
AF:
0.0712
Gnomad EAS
AF:
0.141
Gnomad SAS
AF:
0.146
Gnomad FIN
AF:
0.0955
Gnomad MID
AF:
0.142
Gnomad NFE
AF:
0.126
Gnomad OTH
AF:
0.108
GnomAD2 exomes
AF:
0.112
AC:
20027
AN:
179064
AF XY:
0.120
show subpopulations
Gnomad AFR exome
AF:
0.0224
Gnomad AMR exome
AF:
0.0461
Gnomad ASJ exome
AF:
0.0733
Gnomad EAS exome
AF:
0.146
Gnomad FIN exome
AF:
0.0955
Gnomad NFE exome
AF:
0.131
Gnomad OTH exome
AF:
0.112
GnomAD4 exome
AF:
0.128
AC:
133735
AN:
1042386
Hom.:
9316
AF XY:
0.130
AC XY:
69187
AN XY:
531696
show subpopulations
African (AFR)
AF:
0.0229
AC:
551
AN:
24092
American (AMR)
AF:
0.0494
AC:
1622
AN:
32822
Ashkenazi Jewish (ASJ)
AF:
0.0695
AC:
1519
AN:
21864
East Asian (EAS)
AF:
0.129
AC:
4655
AN:
36056
South Asian (SAS)
AF:
0.170
AC:
11468
AN:
67390
European-Finnish (FIN)
AF:
0.0983
AC:
4902
AN:
49862
Middle Eastern (MID)
AF:
0.130
AC:
632
AN:
4868
European-Non Finnish (NFE)
AF:
0.135
AC:
102762
AN:
759578
Other (OTH)
AF:
0.123
AC:
5624
AN:
45854
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
5556
11112
16669
22225
27781
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3276
6552
9828
13104
16380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0907
AC:
13794
AN:
152086
Hom.:
798
Cov.:
31
AF XY:
0.0903
AC XY:
6714
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.0255
AC:
1061
AN:
41566
American (AMR)
AF:
0.0724
AC:
1105
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.0712
AC:
247
AN:
3468
East Asian (EAS)
AF:
0.141
AC:
732
AN:
5174
South Asian (SAS)
AF:
0.146
AC:
704
AN:
4826
European-Finnish (FIN)
AF:
0.0955
AC:
1012
AN:
10592
Middle Eastern (MID)
AF:
0.129
AC:
38
AN:
294
European-Non Finnish (NFE)
AF:
0.126
AC:
8566
AN:
67892
Other (OTH)
AF:
0.108
AC:
227
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
625
1249
1874
2498
3123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
160
320
480
640
800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.102
Hom.:
172
Bravo
AF:
0.0863
Asia WGS
AF:
0.109
AC:
376
AN:
3470

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139478143; hg19: chr7-16298498; API